Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
NCT00387309
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
495
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Operative Bowel Dysfunction
Interventions
DRUG:
Methylnaltrexone (MOA-728)
Sponsor
Bausch Health Americas, Inc.